Basf India Ltd vs Epigral Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of BASF India Ltd is ₹ 3430 as of 18 Mar 15:30 . The P/E Ratio of BASF India Ltd changed from 25.6 on March 2024 to 0 on March 2023 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Epigral Ltd changed from 23.3 on March 2024 to 11.1 on March 2023 . This represents a CAGR of -13.78% over 5 years The Market Cap of BASF India Ltd changed from ₹ 14443 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Epigral Ltd changed from ₹ 4553 crore on March 2024 to ₹ 3919 crore on March 2023 . This represents a CAGR of -2.96% over 5 years The revenue of BASF India Ltd for the Dec '25 is ₹ 3874 crore as compare to the Sep '25 revenue of ₹ 3927 crore. This represent the decline of -1.34% The revenue of Epigral Ltd for the Dec '25 is ₹ 602.68 crore as compare to the Sep '25 revenue of ₹ 589.1 crore. This represent the growth of 2.31% The ebitda of BASF India Ltd for the Dec '25 is ₹ 181.81 crore as compare to the Sep '25 ebitda of ₹ 186.24 crore. This represent the decline of -2.38% The ebitda of Epigral Ltd for the Dec '25 is ₹ 108.26 crore as compare to the Sep '25 ebitda of ₹ 133.8 crore. This represent the decline of -19.09% The net profit of BASF India Ltd changed from ₹ 220.57 crore to ₹ 106.67 crore over 7 quarters. This represents a CAGR of -33.97% The net profit of Epigral Ltd changed from ₹ 85.87 crore to ₹ 39.11 crore over 7 quarters. This represents a CAGR of -36.20% The Dividend Payout of BASF India Ltd changed from 7.83 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Epigral Ltd changed from 5.88 % on March 2023 to 7.26 % on March 2025 . This represents a CAGR of 7.28% over 3 years .

About BASF India Ltd

BASF India Limited, the flagship company of the BASF Group in India was incorporated as 'R A Cole Private Limited' on May 13, 1943 and the name was changed to Indoplast Limited in January, 1963.
The Company got their name changed to BASF India Limited in February, 1999. BASF India Limited is a leading transnational company in the Indian chemical industry.
The company's portfolio is organized into 6 segments: Agricultural Solutions, Materials, Industrial solutions, Surface Technologies, Nutrition & Care and Chemicals.
The Agricultural Solutions business includes products for crop protection like insecticides, herbicides, fungicides and plant growth regulators.
The Performance Products segment includes the Performance Chemicals, Dispersions & Pigments, Care Chemicals, Nutrition & Health products and Paper Chemicals businesses.

About Epigral Ltd

Epigral Limited was erstwhile incorporated as 'Meghmani Finechem Limited' in 2007, which is engaged in manufacturing and selling of Chlor Alkali & its Derivatives and also in Trading of Agrochemical products.
The Company was incorporated as a subsidiary of Meghmani Organics Limited. Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern, through the Scheme of Arrangement for Demerger and the said Scheme became effective from May 10, 2021.
The Chlor-Alkali business commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 2020-21.
The Company is now among the leading players in India's chlor alkali industry.
In terms of the said Scheme, the Company allotted 2,39,03,029 Equity Shares of Rs 10/- each on 20th May, 2021 to the shareholders of Meghmani Organics Limited.

FAQs for the comparison of BASF India Ltd and Epigral Ltd

Which company has a larger market capitalization, BASF India Ltd or Epigral Ltd?

Market cap of BASF India Ltd is 14,848 Cr while Market cap of Epigral Ltd is 3,694 Cr

What are the key factors driving the stock performance of BASF India Ltd and Epigral Ltd?

The stock performance of BASF India Ltd and Epigral Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for BASF India Ltd and Epigral Ltd?

As of March 18, 2026, the BASF India Ltd stock price is INR ₹3430.45. On the other hand, Epigral Ltd stock price is INR ₹856.45.

How do dividend payouts of BASF India Ltd and Epigral Ltd compare?

To compare the dividend payouts of BASF India Ltd and Epigral Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.